Efficacy and harms of tocilizumab for the treatment of covid-19 patients: a systematic review and meta-analysis

HIGHLIGHTS

• who: Alejandro Piscoya et al. from the Unidad de Revisiones Sistemau0301ticas y Meta-anau0301lisis (URSIGET), Universidad San Ignacio de Loyola have published the research: Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis, in the Journal: PLOS ONE of April/13,/2021
• what: ROBINS-I evaluates seven bias domains: due to confounding, selection of participants into the study, classification of interventions, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result. There were two studies with no dose reported . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.